RxDoctor Payments Data

John Perry, MD

Vascular Surgery · Marietta, GANPI 1578644258

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,806 of the $3,161 with a category attached, or 88.8%. It is spread thinly across 23 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $997 and has fallen 79.2% since, to $208 in 2025. That places this record below the midpoint for vascular surgery clinicians in GA, where the typical reported total is $5,638.

$3,161in general payments, 2019–2025

Across 102 payments — averaging $30.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$615
  • Bard Peripheral Vascular, Inc.$548
  • Cardiovascular Systems Inc.$494
  • Phraxis, Inc.$341
  • Merit Medical Systems Inc$253
  • Avenu Medical Inc.$110
  • plus $800 from 17 others
$37,006in research payments, 2019–2025

Across 6 payments — averaging $6167.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Phraxis, Inc.$37K

What the payments were for

  • Travel & lodging$35511%
  • Food & beverage$2,80689%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,161 in reported general payments places this provider in the 35th percentile of 176 vascular surgery providers in Georgia.

See all vascular surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$207,534
Medicare patients
282
Services billed
1,417

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$25,354
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen176$1,443
ClopidogrelClopidogrel Bisulfate75$907
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen47$565
Cephalexin27$285
Prednisone101$115

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →